Miragen Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Miragen Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Miragen Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Miragen Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $12M | 516k | 22.75 |
| 2024-06-30 | $6.3M | 484k | 13.01 |
| 2024-03-31 | $7.4M | 424k | 17.51 |
| 2023-12-31 | $8.1M | 371k | 21.78 |
| 2023-09-30 | $4.8M | 313k | 15.34 |
| 2023-06-30 | $2.8M | 116k | 23.79 |
| 2023-03-31 | $2.6M | 104k | 25.44 |
| 2022-12-31 | $3.0M | 102k | 29.21 |
| 2022-09-30 | $1.5M | 74k | 20.52 |
| 2022-06-30 | $790k | 68k | 11.58 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management